Skip to content

PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

PLOS BLOGS Speaking of Medicine and Health

This Week in PLOS Medicine: Pharma research; ART & TB; Gestational diabetes & more

Image Credit: Dave Goehring

Five new articles published this week in PLOS Medicine:

Jill Fisher and Corey Kalbaugh describe their findings from a qualitative study evaluating the motivations of private-sector physicians conducting contract research for the pharmaceutical industry.

In a systematic review and meta-analysis, Amitabh Suthar and colleagues investigate the association between antiretroviral therapy and the reduction in incidence of TB in adults with HIV infection.

Jane Hirst and colleagues examined the prevalence and outcome of gestational diabetes mellitus in urban Viet Nam and find that choice of criteria greatly affected prevalence, and has implications for the ability of the health system to cope with the number of cases.

Yanis Ben Amor and Timothy Sullivan call for more research to examine whether the diagnosis and treatment of diabetes in TB patients may improve TB outcomes and patient survival.

Andrew Prendergast and colleagues consider the evidence for a change in policy for the treatment of young children infected with HIV.

Remember you can comment on, annotate and rate any PLOS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

Back to top